Business Description
Athersys was a Cleveland, Ohio-based company focused on developing stem cell treatments for serious medical conditions, including neurological, cardiovascular, and immune disorders. Its lead product, MultiStem, was designed to work across a broad range of patients without requiring a donor match. Founded in 1995, the company pursued this work for nearly three decades before running into financial difficulties. After filing for bankruptcy protection in early 2024, its case was converted from a reorganization to a liquidation by September of that year.
